A major advance in cancer study is arising with the use of nanobodies to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in various types of cancer, causing uncontrolled https://sitesrow.com/story12015706/mini-antibodies-restore-p53-a-potential-pathway-for-tumor-treatment